Does GLP-1 receptor agonist use increase thyroid autoimmunity risk in patients with family history of Hashimoto's thyroiditis?
Origin: "A friend asked if GLP-1 drugs affect him because his mom has Hashimoto's"
847
156
Weekly
2026-04-28
Epistemic Status: Insufficient
Question is real. Not enough data yet. Recruiting contributors.
Current Findings
Key Papers (5)
GLP-1 Receptor Agonists and Thyroid C-Cell Tumors: A Systematic Review
Thyroid · 2024 · Cited in evidence chain
Semaglutide and Autoimmune Thyroiditis: Post-Marketing Surveillance Data
JCEM · 2025 · Cited in evidence chain
Immunomodulatory Effects of GLP-1 Receptor Activation
Nature Reviews Immunology · 2023 · Cited in evidence chain
Th17/Treg Balance in Hashimoto's Thyroiditis: A Meta-Analysis
Autoimmunity Reviews · 2024
Gut Microbiome Changes During GLP-1 Agonist Therapy
Gut · 2025 · Cited in evidence chain
Candidate Questions from Blast Radius
Does GLP-1 affect Th17/T-reg balance across autoimmune conditions?
InvestigateDo SCFAs from GLP-1-induced gut changes modulate thyroid autoimmunity?
Not YetIs the thyroid C-cell signal in rodent studies relevant to human Hashimoto's?
InvestigateDoes semaglutide vs. tirzepatide differ in autoimmune thyroid risk?
Not YetA question rejected today is not a bad question. It might be a premature question. Like continental drift. Like H. pylori. The system remembers what it was curious about.
Oracle Schedule
Epistemic Status Scale
Related Living Queries
Help Answer This Question
Your data, expertise, or funding can help move this query from Insufficient to the next level.
View Campaign →Does GLP-1 receptor agonist use increase thyroid autoimmunity risk in patients with family history of Hashimoto's thyroiditis?
Origin: "A friend asked if GLP-1 drugs affect him because his mom has Hashimoto's"
847
156
Weekly
2026-04-28
Epistemic Status: Insufficient
Question is real. Not enough data yet. Recruiting contributors.
Current Findings
Key Papers (5)
GLP-1 Receptor Agonists and Thyroid C-Cell Tumors: A Systematic Review
Thyroid · 2024 · Cited in evidence chain
Semaglutide and Autoimmune Thyroiditis: Post-Marketing Surveillance Data
JCEM · 2025 · Cited in evidence chain
Immunomodulatory Effects of GLP-1 Receptor Activation
Nature Reviews Immunology · 2023 · Cited in evidence chain
Th17/Treg Balance in Hashimoto's Thyroiditis: A Meta-Analysis
Autoimmunity Reviews · 2024
Gut Microbiome Changes During GLP-1 Agonist Therapy
Gut · 2025 · Cited in evidence chain
Candidate Questions from Blast Radius
Does GLP-1 affect Th17/T-reg balance across autoimmune conditions?
InvestigateDo SCFAs from GLP-1-induced gut changes modulate thyroid autoimmunity?
Not YetIs the thyroid C-cell signal in rodent studies relevant to human Hashimoto's?
InvestigateDoes semaglutide vs. tirzepatide differ in autoimmune thyroid risk?
Not YetA question rejected today is not a bad question. It might be a premature question. Like continental drift. Like H. pylori. The system remembers what it was curious about.
Oracle Schedule
Epistemic Status Scale
Related Living Queries
Help Answer This Question
Your data, expertise, or funding can help move this query from Insufficient to the next level.
View Campaign →